This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (10)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in this journal  Topic Collections  • Hypertension  • Alert me on articles by topic  Social Bookmarking   What's this?

Lessons From 1000 Operations and 50 Years' Experience

Héctor Orozco, MD; Miguel Angel Mercado, MD

Arch Surg. 2000;135:1389-1393.

Hypothesis  Surgery for portal hypertension has evolved widely in the past decades. Selection criteria and the type of operations have evolved because of the appearance of other therapeutic alternatives, such as pharmacotherapy, endoscopic therapy, transjugular intrahepatic portosystemic shunt, and liver transplantation. We believe the surgical approach has a therapeutic role in a select patient population.

Design  Retrospective review of the medical records of patients operated on for bleeding portal hypertension in the past 50 years.

Setting  An academic tertiary care university hospital.

Patients and Methods  In a 50-year period, 1000 operations for the treatment of bleeding portal hypertension have been done, including shunts and devascularization procedures. In the past years, in low-risk (Child-Pugh classification A) selected patients, only portal blood flow–preserving operations have been done.

Results  Non–portal blood flow–preserving procedures had a wide spectrum of results, with a high encephalopathy rate and short long-term survival. The results with portal blood flow–preserving procedures in the past 10 years are as follows: operative mortality, 2.7%; postoperative encephalopathy, 6%; rebleeding, 6%; and shunt obstruction, 4%.

Conclusions  Portal hypertension surgery has a role in elective operations and in low-risk selected patients, when portal blood flow–preserving procedures are done. The type of operation is selected according to the individual characteristics of each patient.

From the Portal Hypertension Clinic, Instituto Nacional de la Nutrición, "Salvador Zubirán," Tlalpan, Mexico.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

The Evolution of Portal Hypertension Surgery—Invited Critique
John Terblanche
Arch Surg. 2000;135(12):1394.
EXTRACT | FULL TEXT  

Archives of Surgery Reader's Choice: Continuing Medical Education
Arch Surg. 2000;135(12):1479-1480.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Rise and Downfall of the Empire of Portal Hypertension Surgery
Orozco and Mercado
Arch Surg 2007;142:219-221.
FULL TEXT  

Distal Splenorenal Shunt: Preferred Treatment for Recurrent Variceal Hemorrhage in the Patient With Well-Compensated Cirrhosis
Elwood et al.
Arch Surg 2006;141:385-388.
ABSTRACT | FULL TEXT  

Splenorenal Shunt: An Ideal Procedure in the Pacific
Wong et al.
Arch Surg 2002;137:1125-1129.
ABSTRACT | FULL TEXT